Meta facebook tracking pixel

Listen Now

Topics Covered

  • Overview of Blood Cancers, in the Context of COVID-19
  • New Research Presented at ASH
  • Disease-Specific Treatment Updates from ASH on Leukemia, Lymphoma, Multiple Myeloma and Myeloproliferative Neoplasms (MPN)
  • The Role of Precision Medicine & Clinical Trials
  • Talking with Your Health Care Team about Your Treatment Options
  • Communicating with Your Health Care Team with Telehealth/Telemedicine Appointments
  • Guidelines to Prepare for These Appointments
  • Key Questions to Ask Your Health Care Team
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts


Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine


Nilanjan Ghosh, MD, PhD, FACP

Kerry and Simone Vickar Family Foundation Endowed Chair, Chair, Department of Hematologic Oncology and Blood Disorders, Chief, Lymphoma Division, Levine Cancer Institute, Atrium Health, Charlotte, NC, Clinical Professor of Internal Medicine, Wake Forest University School of Medicine


Matthew J. Butler, MD

Assistant Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Mays MD Anderson Cancer Center, UT Health San Antonio


Ruben A. Mesa, MD, FACP

President, Levine Cancer Institute, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Enterprise Senior Vice President Atrium Health, Vice Dean for Cancer Programs – Wake Forest School of Medicine, Professor of Medicine Wake Forest School of Medicine


Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on December 14, 2023.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.